3475-S Edison Way
Menlo Park, CA
United States of America, California
Developer of therapeutic protein conjugates with enhanced potency and decreased immunogenicity.
Specializing in receptor-binding ligands, receptors and enzymes.
Provider of proprietary technology for cost-effective production of unusually homogeneous conjugates with lower immunoreactivity than conventional PEG conjugates.
Inquire about patent licenses available in your fields of interest.
Strictest confidentiallity can be assured.